News
Discover Magazine on MSN14h
FDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. In two groundbreaking ...
In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.
Dailymotion on MSN13m
US FDA approves Gilead’s twice-yearly injection for HIV preventionThe US Food and Drug Administration approves Wednesday, June 18, Gilead Sciences lenacapavir, a twice-yearly injection, for ...
HealthDay on MSN6m
FDA Approves First Twice-a-Year HIV Prevention ShotKey Takeaways A new HIV shot taken twice a year was nearly 100% effective in trialsGlobal funding cuts could limit access to ...
The United States Food and Drug Administration (FDA) has approved long-acting injectable lenacapavir for HIV prevention. The ...
The US Food and Drug Administration (FDA) has approved use of the vaccine Yeztugo, manufactured by Gilead Sciences, is an anti-HIV drug.
A United Nations agency has urged the pharmaceutical company Gilead Sciences to lower the price of the long acting antiviral treatment lenacapavir following the US Food and Drug Administration (FDA)’s ...
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback